Investors trying to capitalize on some of the best growth leaders in the markets today may turn to exchange traded funds based off Investor’s Business Daily high-conviction picks.
“Our first ones are based on Investor’s Business Daily research that’s been out forever, and that individual investors love, but they didn’t really have a way to access it and really participate and didn’t understand the products. So we’re working with IBD to bring products based on their research and their following,” Bruce Bond, CEO of Innovator ETFs, said at the Inside ETFs 2018 conference.
Bond also illustrated the point that Innovator also tries to help investors achieve defined outcomes, or “to be able to provide more definitive outcomes to people that are investing in ETFs and in the market in general.”
Regular readers of Investor’s Business Daily may be well-acquainted with the publication’s venerable IBD 50, a group of fundamentally sound leading stocks displaying impressive relative strength.